Innovations In Atrial Fibrillation And Impact On The Brain

Atrial fibrillation (AF) is the most common form of arrhythmia and one of the leading causes of thromboembolic stroke. Because its prevalence increases with age, it is estimated that more than 6 million individuals will be affected with AF by 2050. It is critical that cardiologists and other clinicians are able to accurately assess and manage stroke risk, identify and utilize effective treatment strategies, and improve long-term outcomes in their patients. The program will highlight the diagnosis and management of AF and guidelines to improve the evaluation of stroke risk and appropriate use of antithrombotic therapies for stroke prevention in patients with AF. The goal of this program is to improve the evaluation of stroke risk and appropriate management for stroke prevention in patients with atrial fibrillation.

Booking: http://atnd.it/53882-1

Category: Conferences, Science, Health and Medicine, Cardiology

Price:
450: USD 1

Speakers: Douglas L. Packer, M.D., Samuel J. Asirvatham, M.D., Paul A. Friedman, M.D., Suraj Kapa, M.D., Peter A. Noseworthy, M.D., Alejandro A. Rabinstein, M.D., Win-Kuang Shen, M.D., Thomas M. Munger, M.D., Jeanne E. Poole, M.D., Dhanunjaya Lakkireddy, M.D., Jared Bunch, M.D. soon Park, M.D., Rajiv Pruthi, M.D.